Craig F. Burns

Craig F. Burns, PhD MS has a diverse work experience in the pharmaceutical and healthcare industry. Craig F. currently serves as the Vice President of Program Management at Jasper Therapeutics. Prior to that, they worked as the Senior Director of Strategic Planning & Project Management at NextCure, Inc., where they were responsible for developing and updating the company's strategic five-year plan.

Before joining NextCure, Inc., Craig held leadership roles at America's Health Insurance Plans (AHIP): The Center for Policy and Research. Craig F. served as the Vice President of Research, overseeing the development and execution of the research agenda in alignment with AHIP's strategic plan. Craig F. also worked as a Senior Director of Research at the same organization, leading various research studies focused on pharmacy-related topics and drug pricing trends.

Earlier in their career, Craig gained extensive experience in the pharmaceutical industry. Craig F. worked as a Project Director of Oncology R&D at Sanofi, leading multinational project teams in the creation and execution of development strategies for regulatory approvals. Craig F. also served as a Project Manager of R&D at MedImmune, where they managed timelines and coordinated development activities across multiple therapeutic areas.

Craig's career began at British Biotech, where they worked as a Regulatory Affairs Associate. In this role, they were responsible for preparing IND submissions to regulatory agencies and authored a literature review for an FDA pre-IND meeting package.

Overall, Craig F. Burns, PhD MS has a strong background in program management, strategic planning, research, and regulatory affairs in the healthcare and pharmaceutical industry.

Craig F. Burns, PhD MS obtained their Bachelor of Arts degree in Chemistry from The University of Tulsa between the years 1986 and 1991. Craig F. then pursued a Master of Science degree in Toxicology from Oklahoma State University from 1992 to 1996. Later on, from 2009 to 2014, they earned their PhD in Clinical and Administrative Pharmacy from the University of Oklahoma Health Sciences Center. Additionally, they have undergone additional training, though the specific details are not provided.